Literature DB >> 22078419

Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review.

Benoit Daneault1, Ajay J Kirtane, Susheel K Kodali, Mathew R Williams, Philippe Genereux, George R Reiss, Craig R Smith, Jeffrey W Moses, Martin B Leon.   

Abstract

Stroke is a potential complication of treating patients with aortic stenosis via surgical aortic valve replacement (AVR), transcatheter aortic valve replacement (TAVR), and balloon aortic valvuloplasty. Because there are limited and heterogeneous data on the incidence, risk factors, and outcomes of stroke among patients being treated for aortic stenosis, we performed a comprehensive review of the literature. The risk of stroke after AVR in the general population is approximately 1.5%, and the risk is increased (to approximately 2% to 4%) in older and higher-risk patients. Strokes were reported in 1.5% to 6% of patients treated with TAVR, and in the only randomized trial of AVR versus TAVR, there was an increased risk of 30-day strokes (minor and major strokes and transient ischemic attacks) with TAVR (5.5% vs. 2.4%, p = 0.04). Copyright Â
© 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22078419     DOI: 10.1016/j.jacc.2011.08.024

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

Review 1.  Clinical studies assessing transcatheter aortic valve replacement.

Authors:  Shaheena Raheem; Jeffrey J Popma
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Apr-Jun

Review 2.  [Interventional therapy of aortic valve stenosis in Germany].

Authors:  C W Hamm; T Bauer
Journal:  Internist (Berl)       Date:  2016-04       Impact factor: 0.743

3.  Shifting paradigms for treatment of symptomatic aortic stenosis in lower risk populations: role of a newer generation balloon-expandable transcatheter aortic valve implantation device.

Authors:  Erik Walter Holy; Mohamed Abdel-Wahab
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

Review 4.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

Review 5.  Incidence, predictors, origin and prevention of early and late neurological events after transcatheter aortic valve implantation (TAVI): a comprehensive review of current data.

Authors:  Philipp Kahlert; Fadi Al-Rashid; Björn Plicht; Heike Hildebrandt; Polykarpos Patsalis; Karim El Chilali; Daniel Wendt; Matthias Thielmann; Lars Bergmann; Eva Kottenberg; Marc Schlamann; Holger Eggebrecht; Heinz Jakob; Gerd Heusch; Thomas Konorza; Raimund Erbel
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

Review 6.  Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies.

Authors:  Ziad Sergie; Thierry Lefèvre; Eric Van Belle; Socrates Kakoulides; Usman Baber; Efthymios N Deliargyris; Roxana Mehran; Eberhard Grube; Jochen Reinöhl; George D Dangas
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

Review 7.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

8.  Cognitive function after transapical aortic valve implantation: a single-centre study with 3-month follow-up.

Authors:  Stephan C Knipp; Philipp Kahlert; Daniel Jokisch; Marc Schlamann; Daniel Wendt; Christian Weimar; Heinz Jakob; Matthias Thielmann
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-11

Review 9.  Transcatheter aortic valve replacement: current application and future directions.

Authors:  Amir-Ali Fassa; Dominique Himbert; Alec Vahanian
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

10.  Experimental Study and Early Clinical Application Of a Sutureless Aortic Bioprosthesis.

Authors:  Walter J Gomes; João Carlos Leal; Fabio Biscegli Jatene; Nelson A Hossne; Renata Gabaldi; Glaucia Basso Frazzato; Guilherme Agreli; Domingo M Braile
Journal:  Braz J Cardiovasc Surg       Date:  2015 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.